Evexia Lifecare’s share price rose over 3% on Monday, marking its second straight session of gains. The penny stock climbed 3.44% to ₹1.80 on the BSE, supported by strong trading activity. Nearly 20 lakh shares changed hands on November 17, higher than the weekly average of 17 lakh shares.
Evexia Lifecare is a small-cap healthcare company engaged in trading pharmaceutical chemicals, operating retail pharmacies, offering diagnostic services, and selling personal healthcare products. Its core business is pharma chemical trading, which contributes the most to its revenue.
The company recently posted its Q2 FY26 results, reporting a consolidated net profit of ₹37.19 lakh, significantly lower than ₹93.80 lakh in the same quarter last year and ₹63.48 lakh in Q1 FY26. Revenue from operations stood at ₹25.72 crore, compared to ₹26.70 crore YoY, though higher than ₹22.09 crore in the June quarter.
Despite Monday’s gain, the stock has seen a steep decline over the past year—down 13% in a month, 24% in three months, 36% in six months, and 50% year-to-date, with a 56% drop over one year. At 2:50 p.m., the stock was trading at ₹1.75, up 0.57%.
+ There are no comments
Add yours